Skip to main content
Signal8

Weiler Peter J.

SEC insider (Form 3/4/5 filer). CIK 0002066576. Chief Financial Officer at Edesa Biotech, Inc. (EDSA). 2 reported Form 4/5 transactions since Sep 2024; latest on May 27, 2026. Located in MARKHAM.

Companies Weiler Peter J. has filed insider reports for

  • Edesa Biotech, Inc. (EDSA): Officer, Chief Financial Officer
Weiler Peter J. profile photo

Weiler Peter J.

CIK: 0002066576

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)2 (100.0%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

Edesa Biotech, Inc. logo
EDSA

Edesa Biotech, Inc.

Officer

Discretionary Trading P&L

Holdings

Transaction History (2 total)

  • Edesa Biotech, Inc. logo
    EDSA

    Edesa Biotech, Inc.

    May 27, 2026
    Award
    Direct
    64.6K shares-
  • Edesa Biotech, Inc. logo
    EDSA

    Edesa Biotech, Inc.

    May 29, 2025
    Award
    Direct
    65K shares-

1-2 of 2